Augmentation of Mouse Natural Killer (NK) Activity by GM-1/P, A Processed form of Monosialoganglioside GM-1

References

• Herberman R. B. NK cells and natural effector cells, R. B. Herberman. Academic Press, New York 1982
   Google Scholar
• Trinchieri G. Biology on natural killer cells. Adv. Immunol. 1989; 47: 187
   PubMed Web of Science ®Google Scholar
• Timonem T., Ortaldo J. R., Herberman R B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 1981; 153: 569
   PubMedGoogle Scholar
• Herberman R. B., Santoni A. Regulation of natural killer (NK) cell activity. Biological Response in Cancer: Progress toward Potential Application, E. Mihich. Plenum Press, New York 1984; 121
   Google Scholar
• Welsh R. M. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 1978; 148: 163
   PubMed Web of Science ®Google Scholar
• Djeu J. Y., Huang K. Y., Herberman R. B. Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J. Exp. Med. 1980; 151: 781
   PubMed Web of Science ®Google Scholar
• Wolf S. A., Tracey D. E., Henney C. S. Induction of natural killer cells by BCG. Nature 1977; 262: 584
   Google Scholar
• Santoni A., Puccetti P., Riccardi C., Herberman R. B., Bonmassar E. Augmentation of natural killer activity by pyran coplymer in mice. Int. J. Cancer 1979; 24: 656
   PubMed Web of Science ®Google Scholar
• Oehler J. R., Herberman R. B. Natural cell-mediated cytotoxicity in rats. III. Effect of immunopharmacologic treatments of natural reactivity augmented by polyinosinic-polycytidilic acid. Int. J. Cancer 1978; 21: 221
   PubMed Web of Science ®Google Scholar
• Lotzova E., Savary C. A., Khan A., Stringfellow D. A. Cytotoxic and morphologic profile of endogenous and pirimidone -activated murine NK cells. J. Immunol. 1986; 136: 732
   PubMed Web of Science ®Google Scholar
• Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 1979; 122: 175
   PubMed Web of Science ®Google Scholar
• Gidlund M., Om H., Wigzell H., Senik A., Gresser I. Enhanced NK cell activity in mice injected with interferon inducers. Nature 1978; 273: 759
   PubMed Web of Science ®Google Scholar
• Timonem T., Ortaldo J. R., Herberman R. B. Analysis by single cytotoxicity assay of natural killer (NK) cell frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J. Immunol. 1982; 128: 2514
   PubMedGoogle Scholar
• Biron C. A., Welsh R. M. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 1982; 129: 2514
   Google Scholar
• Biron C. A., Turgiss L. R., Welsh R. M. Increase in NK cell number and turnover rate during acute viral infection. J. Imunol. 1983; 131: 1539
   PubMed Web of Science ®Google Scholar
• Santoni A., Piccoli M., Ortaldo J. R., Mason L., Wiltrout R. H., Herberman R. B. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity. J. Immunol. 1985; 134: 2799
   PubMed Web of Science ®Google Scholar
• Santoni A., Piccoli M., Forni G., Herberman R. B., Frati L. Mechanisms of cytotoxicity by NK cells, R. B. Herberman. Academic Press, Orlando 1985; 433
   Google Scholar
• Testi R., Galli M. C., Piccoli M., Herberman R. B., Frati L., Santoni A. Sequential metabolic events and morphological changes during in vivo large granular lymphocyte activation and proliferation. Cell. Immunol. 1986; 102: 78
   PubMedGoogle Scholar
• Wiltrout R. H., Mathieson B. J., Talmadge J. L., Reynolds C. W., Zhang S., Herberman R. B. Augmentation of organ-associated NK activity by biological response modifiers: isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 1984; 160: 1431
   PubMed Web of Science ®Google Scholar
• Kuribayashi K., Gillis S., Kern D. E., Henney C. S. Murine cell cultures: effects of interleukin-2 and interferon on cell and cytotoxic activity. J. Immunol. 1982; 126: 2321
   Google Scholar
• Hefeneider S. H., Conlon P. J., Henney C. S., Gillis S. In vivo interleukin-2 administration augment the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J. Immunol. 1983; 130: 222
   PubMed Web of Science ®Google Scholar
• Grim E. A., Rosenberg S. A. The human lymphokine-activated killer cell phenomenon. Lymphokines 1983; 9: 435
   Google Scholar
• Herberman R. B., Hiserodt J., Vujanovic N., et al. Lymphokine-activated killer cell activity. Characteristics of effector cells and their progenitors in blobd and spleen. Immunol. Today 1987; 8: 178
   PubMedGoogle Scholar
• Punturieri A., Velotti F., Piccoli M., Herberman R. B., Frati L., Santoni A. Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoided of LGL. Clin. Exp. Immunol. 1989; 75: 155
   PubMedGoogle Scholar
• Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Ann. Rev. Biochem. 1981; 50: 733
   PubMed Web of Science ®Google Scholar
• Marcus D. M. A review of the immunogenic and imunomodulatory properties of glycosphingolipids. Mol. Immunol. 1984; 21: 1083
   PubMed Web of Science ®Google Scholar
• Krishnaraj R., Linn J., Kemp R. G. Lectin-and ionophore-stimulated Ca++ influx in murine lymphocytes: inhibition by disialoganglioside. Cell. Imunol. 1983; 78: 152
   PubMedGoogle Scholar
• Lengle E. E., Krishnaraj R., Kemp R. G. Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids. Cancer Res. 1979; 39: 817
   PubMedGoogle Scholar
• Whisler R. L., Yates A. J. Regulation of lymphocyte responses by human gangliosides. J. Imunol. 1980; 125: 2106
   PubMed Web of Science ®Google Scholar
• Ladish S., Gillard B., Wong C., Ulsh L. Shedding and imunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 1983; 43: 3808
   PubMedGoogle Scholar
• Marcus D. M., Dustira A., Diego I., Osovitz S, Lewis D E. Studies of the mechanism by which gangliosides inhibit the proliferative response of murine splenocytes to Concanavalin A. Cell Immunol. 1987; 124: 71
   Google Scholar
• Merrit W. D., Bailey J. M., Pluznik D. H. Inhibition of interleukin-2 dependent cytotoxic T-lymphocytes growth by gangliosides. Cell. Immunol. 1984; 89: 1
   PubMed Web of Science ®Google Scholar
• Parker J., Caldini G., Krisnamurti C., Ahrens P. B., Ankel H. Binding of interleukin-2 to gangliosides. FEBS 1984; 170: 391
   PubMedGoogle Scholar
• Robb R. J. The suppressive effect of gangliosides upon IL-2 dependent proliferation as a function of inhibition IL-2 receptor association. J. Inununol. 1986; 136: 971
   Google Scholar
• Jackson K. M., Yates A. J., Orosz C. G., Whitacre C. C. Gangliosides suppress the proliferation of autoreactive cells in experimental allergic encephalomyelitis: ganglioside effect on IL-2 activity. Cell. Immunol. 1987; 104: 169
   PubMedGoogle Scholar
• Spiegel S., Fishman P. H., Weber R. J. Direct evidence that endogenous GM1 ganglioside can mediate thymocyte proliferation. Science 1985; 230: 1285
   PubMed Web of Science ®Google Scholar
• Welte K., Miller G., Chapman P. B., et al. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J. Immunol. 1987; 139: 1763
   PubMed Web of Science ®Google Scholar
• Hersey P., Schibeci S. D., Townsend P., Bums C., Cheresh D. A. Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3. Cancer Res. 1986; 46: 6083
   PubMed Web of Science ®Google Scholar
• Spiegel S., Wilchek M. Membrane sialoglycolipids emerging as possible signal transducers for lymphocyte stimulation. J. Immunol. 1981; 127: 572
   PubMedGoogle Scholar
• Offner H., Konat G., Sela B. Multisialo brain gangliosides are powerful stimulators of active E-rosetting lymphocytes from multiple sclerosis patients J. Neurol. Sci. 1981; 52: 279
   Google Scholar
• Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived, murine lymphocytes. Eur. J. Immunol. 1973; 3: 645
   PubMed Web of Science ®Google Scholar
• Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor:parameters of production and quantitative microassay for activity. J. Immunol. 1978; 120: 2027
   PubMed Web of Science ®Google Scholar
• Cavaillon J. M., Fitting C., Hauttecoeur B., Haeffner-Cavaillon N. Inhibition by ganglioside of lipopolysaccharide (LPS) to human monocyte prevents LPS-induced interleukin-1 production. Cell. Immunol. 1987; 106: 293
   PubMedGoogle Scholar
• Santoni A., Velotti F., Testi R., Galli M. C., Piccoli M., Herberman R. B., Frati L. Mechanism for in vivo expansion of natural killer cells. Natural Immunity Cancer and Biological Modification, E. Lotzova, R. B. Herberman. Karger Press, Basel 1986; 124
   Google Scholar